Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
Provided By PR Newswire
Last update: Jul 29, 2025
EMERYVILLE, Calif., July 29, 2025 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial stage biopharmaceutical company developing and commercializing innovative vaccines, will report second quarter 2025 financial results on Thursday, August 7, 2025, after the U.S. financial markets close.
Read more at prnewswire.com
